Forgoing bridging anticoagulation offered similar results as bridging with heparin to prevent thromboembolism perioperatively in patients with atrial fibrillation who temporarily halted warfarin ...

Cite this: 'A Bridge Too Far': Analysis Points to Bleeding Risks From Anticoagulation Bridging in AF - Medscape - Dec 16, 2014. References Authors and Disclosures ...

In a new article describing the outcomes of patients included in the ORBIT-AF prospective registry, Steinberg and colleagues find that bridging anticoagulation in individuals with atrial ...

In contrast, when surgery is performed with heparin bridging, such bleeding may remain latent, and appear only when full anticoagulation is resumed postoperatively." ...

Although every case is different, the thromboembolic risk appears low when oral anticoagulation is stopped for outpatient colonoscopy, dental work, or other minor invasive outpatient procedures ...

Although relatively common, use of “bridging” medication to protect A-fib patients during the interruption of anticoagulation for procedures is associated with a greater risk of adverse events, ...

Bridging with a parenteral agent is “rarely, if ever, needed” in NOAC-treated patients because of the short half-lives of the drugs, the authors say, whereas warfarin-treated patients at high ...

According to American Heart Association statistics, approximately 532,000 patients underwent procedures related to implantation of cardiac pacemakers or implantable cardiac defibrillators in 2006 ...

Compared to the heparin arm of the trial, patients receiving warfarin had fewer prolonged hospital stays (1.2 percent vs. 4.8 percent), less re-interruption of anticoagulation (3.3 percent vs. 14. ...

Bridging anticoagulation refers to giving atrial fibrillation patients a short-acting blood thinner, usually by injecting low-molecular-weight heparin for 10 to 12 days around the time of the ...

Warfarin and heparin are anticoagulant medications, or "blood thinners." They help stop your blood from clotting when it’s not necessary. Find out how the two drugs work, and how they differ.

For patients undergoing pacemaker or implantable cardioverter-defibrillator surgery, the incidence of clinically significant pocket-device hematoma is significantly reduced with continued warfarin ...